Additionally, we showed that elevated serum sTfR levels (>2.14 mg/dL) were associated with an increased risk of cardiovascular manifestations, such as myocardial infarction and ischemic heart disease, in patients with SLE. Here, TFRC is linked to myocardial infarction.